Biology-Driven AI Makes Its Presence Felt In Drug Discovery
The quite hectic journey so as to bring a single new drug to the market essentially spans a decade as well as costs an...
Clinical Trials Automation: Step Towards Sustainable Pharma
The pharmaceutical sector is looking for certain transformative strategies so as to stay ahead in an era that is marked by fast technological growth...
Biology-Driven AI Pushing Drug Discovery To Bigger Levels
The painstaking journey to bring one new drug to market almost spans a decade and costs an average of $2.6 billion. The AI as...
Lab Connectivity – Way Forward To Data-Driven Discoveries
Technology has gone on to change almost every aspect when it comes to the daily lives and has swiftly redefined the way one manages...
Digital Innovation In Therapeutics For Faster Market Access
Right from finding potential active substances as well as identifying novel targets to simulating how drugs will perform within the human body and also...
Guidance On CAR-T Cell Product Development Issued By FDA
The FDA has gone on to publish its final guidance on January 30, 2024, that goes on to offer consideration for the development of...
EMA Given Aid To Support African Medicines Agency Setup
The European Medicines Agency- EMA went on to announce on January 26, 2024, that the European Commission-EC has gone ahead and given the agency...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...